Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Mayne Pharma Group Ltd.

AU$2.34

Price Change Indicator
0.085 (3.78%)
Mayne Pharma Group Ltd.
MYX · ASX

Mayne Pharma Group Ltd.

Start Trading MYX for Free

AU$2.34

Price Arrow0.085 (3.78%)
25/03/2026 03:30:08 PM
All-CompaniesGROWTH AUSHALO OrdsHALO SmallHammer BullishHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Mayne Pharma Group Ltd. Overview

MYX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About MYX

icon
icon

Telephone

61.8.8209.2666

icon

Address

Salisbury South, 1538 Main North Road, Salisbury, South Australia (SA) 5106

Description

Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.

MYX Price Chart

Key Stats

Market Cap

AU$200.68M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.04 - 7.28

Trade Value (12mth)

AU$664,013.00

1 week

5.63%

1 month

-11.76%

YTD

-29.47%

1 year

-68.97%

All time high

37.10

Key Fundamentals

EPS 3 yr Growth

-65.30%

EBITDA Margin

11.20%

Operating Cashflow

$21m

Free Cash Flow Return

4.90%

ROIC

-20.90%

Interest Coverage

9.10

Quick Ratio

1.20

Other Data

Shares Outstanding (Fully Diluted)

81m

HALO Sector

Healthcare

Next Company Report Date

20-Aug-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

2.87

MYX Announcements

Latest Announcements

DateAnnouncements
11 March 26
10 March 26
09 March 26
06 March 26
03 March 26

MYX Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-3.85-2.19-1.19locklocklock
EPS (Fully Diluted)
 $locklocklocklock-3.67-2.19-1.19locklocklock
Growth
 %locklocklocklock-12.743.245.8locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

100%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

HALO Consensus Score

PEG Ratio

Consensus EPS Revisions

Short Selling

Key Stats

Percent of Issue

2.87%

Value ($M)

5

Prior Change

0

7 Day Change

-0.10%

1 Month Change

0.20%

3 Months Change

0.80%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

MYX Shortsell

Related Companies

CSL - ASX
CSL Limited

CSL · ASX

CSL Limited

AU$140.90

Price Change Indicator

1.51 (1.08%)

RMD - ASX
ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

RMD · ASX

ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

AU$33.04

Price Change Indicator

0.59 (1.82%)

SIG - ASX
Sigma Healthcare Ltd

SIG · ASX

Sigma Healthcare Ltd

AU$2.65

Price Change Indicator

0.05 (1.92%)

Want to learn more?Frequently asked questions.
What is the current share price of Mayne Pharma Group Ltd. (MYX:ASX)?
Halo FAQ
The current share price of Mayne Pharma Group Ltd. (MYX:ASX) is AUD$2.34.
What is the 52-week high share price for Mayne Pharma Group Ltd. (MYX:ASX)?
Halo FAQ
The 52-week high share price for Mayne Pharma Group Ltd. (MYX:ASX) is AUD$7.28.
What is the 52-week low share price for Mayne Pharma Group Ltd. (MYX:ASX)?
Halo FAQ
The 52-week low share price for Mayne Pharma Group Ltd. (MYX:ASX) is AUD$2.04.
What is the dividend yield for Mayne Pharma Group Ltd. (MYX:ASX)?
Halo FAQ
Mayne Pharma Group Ltd. (MYX:ASX) does not pay a dividend.
What was Mayne Pharma Group Ltd. (MYX:ASX) last dividend payment?
Halo FAQ
The last dividend payment of Mayne Pharma Group Ltd. (MYX:ASX) is AUD$0.03.
What is the franking level for Mayne Pharma Group Ltd. (MYX:ASX)?
Halo FAQ
Mayne Pharma Group Ltd. (MYX:ASX) has a franking level of 100.00%.
In which sector is Mayne Pharma Group Ltd. (MYX:ASX) classified?
Halo FAQ
Mayne Pharma Group Ltd. (MYX:ASX) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial